Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Research crawled date : 2022 - 07 - 20 save search
Blue Water Vaccines Announces Signing of Sponsored Research Agreement with Cincinnati Children’s Hospital Medical Center for S&P Vaccine Platform Development
Published: 2022-07-20 (Crawled : 19:00) - globenewswire.com
BWV | $0.1802 5.44% 530K
|
|
| O: -2.84%
H: 5.85%
C: 0.0%
water research vaccine blue agreement platform
Navidea Biopharmaceuticals Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
Published: 2022-07-20 (Crawled : 14:00) - biospace.com/
NAVB | $0.042 50.69% 12K
|
Health Technology
|
| O: -1.45%
H: 4.41%
C: -13.22%
offering
Synaptogenix Advances Dosing of First Patient in Dose Optimization Clinical Trial in Preparation for NIH-Sponsored, Phase 2 Alzheimer's Disease Trial Data
Published: 2022-07-20 (Crawled : 14:00) - biospace.com/
SNPX | $4.66 -2.92% -3.0% 42K
|
Professional, Scientific, and T...
|
| O: 0.65%
H: 11.11%
C: 5.13%
disease alzheimer's trial phase 2
Rhythm Pharmaceuticals Announces Early Access Authorization for Setmelanotide for Use in Patients with Bardet-Biedl Syndrome in France
Published: 2022-07-20 (Crawled : 14:00) - biospace.com/
RYTM A | $38.11 -0.88% -0.89% 440K
|
Health Technology
|
| O: 2.46%
H: 22.97%
C: 21.86%
authorization setmelanotide
TheStreet Partners With QuoteMedia to Advance Stock Research Tools and Streaming Solutions
Published: 2022-07-20 (Crawled : 14:00) - globenewswire.com
LDNXF | $112.5665 -12.32% 1.3K
|
Finance
|
| O: -1.86%
H: 2.89%
C: 2.89%
LNSTY | $28.6457 0.53% 130K
|
Finance and Insurance
|
| O: -0.04%
H: 0.68%
C: 0.13%
research solutions
Methanol Market to Garner $54.6 Billion, Globally, By 2030 at 5.06% CAGR, Says Allied Market Research
Published: 2022-07-20 (Crawled : 13:20) - prnewswire.com
CE | News | $154.62 0.08% 0.0% 410K
|
Process Industries
|
| O: -0.3%
H: 0.82%
C: 0.15%
MEOH | $47.52 -0.81% -0.86% 310K
|
Process Industries
|
| O: -0.31%
H: 0.28%
C: -0.23%
research market
Aytu BioPharma Announces Initiation of the AR101 PREVEnt Trial for the Treatment of Vascular Ehlers-Danlos Syndrome
Published: 2022-07-20 (Crawled : 13:00) - biospace.com/
AYTU | $2.91 1.28% 1.26% 3.3K
|
Health Technology
|
| O: 3.28%
H: 1.43%
C: -3.56%
ar101 treatment biopharma trial
Upstaza™ Granted Marketing Authorization by European Commission as First Disease-Modifying Treatment for AADC Deficiency
Published: 2022-07-20 (Crawled : 13:00) - biospace.com/
PTCT | $24.71 -1.79% -1.82% 820K
|
Health Technology
|
| O: 1.0%
H: 1.12%
C: -0.36%
treatment granted authorization
Eiger Receives European Approval for Zokinvy® (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies
Published: 2022-07-20 (Crawled : 13:00) - biospace.com/
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: 0.0%
H: 4.18%
C: 2.36%
zokinvy approval
Surgalign Announces the Commercial Relaunch of its Next Generation CervAlign Anterior Cervical Plate System Optimized for Discectomy and Fusion Procedures
Published: 2022-07-20 (Crawled : 13:00) - biospace.com/
SRGA | $0.1829 -50.36% 8.7M
|
Health Technology
|
| O: 5.35%
H: 6.15%
C: 4.31%
system commercial
Vaxart Publishes Clinical Data Suggesting its Oral COVID-19 Pill Vaccine Candidate Induces Long-Lasting Mucosal Immune Responses that are Highly Cross-Reactive
Published: 2022-07-20 (Crawled : 13:00) - biospace.com/
VXRT | $0.836 -3.48% -3.6% 880K
|
Health Technology
|
| O: 2.53%
H: 8.13%
C: 4.93%
covid-19 candidate vaccine
SeaStar Medical Submits Humanitarian Device Exemption Application to FDA for Use of Selective Cytopheretic Device in Children with Acute Kidney Injury Application
Published: 2022-07-20 (Crawled : 13:00) - biospace.com/
LMAO | $12.35 3.89%
|
| Email alert
Add to watchlist
fda device children kidney application
ADC Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of ZYNLONTA® (loncastuximab tesirine-lpyl) in Combination with Rituximab in First-Line Diffuse Large B-Cell Lymphoma
Published: 2022-07-20 (Crawled : 12:00) - biospace.com/
ADCT | $4.76 -4.03% 0.0% 280K
|
Health Technology
|
| O: -0.26%
H: 3.04%
C: 0.53%
zynlonta trial therapeutics phase 2
Ionis announces enrollment completion of Phase 3 Lp(a) HORIZON cardiovascular outcomes study of pelacarsen
Published: 2022-07-20 (Crawled : 12:00) - biospace.com/
IONS | $40.81 -0.24% -0.25% 990K
|
Health Technology
|
| O: -1.73%
H: 1.66%
C: -0.28%
cardiovascular study
Karyopharm Granted Regulatory Designations for Eltanexor for the Treatment of Myelodysplastic Syndromes
Published: 2022-07-20 (Crawled : 12:00) - biospace.com/
KPTI | $1.265 -8.33% -9.09% 1.3M
|
Health Technology
|
| O: 3.84%
H: 7.7%
C: -0.82%
treatment granted
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
Published: 2022-07-20 (Crawled : 12:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
treatment glaucoma
Skye Bioscience Updates Phase 1 Timeline
Published: 2022-07-20 (Crawled : 12:00) - biospace.com/
SKYE | $16.865 -2.85% -2.94% 70K
|
Transportation and Warehousing
|
| O: -3.95%
H: 6.85%
C: 4.11%
bioscience phase 1
Adial Pharmaceuticals Announces Topline Results For Onward™ Phase 3 Trial for AD04 in Patients with Alcohol Use Disorder
Published: 2022-07-20 (Crawled : 12:00) - biospace.com/
ADIL | $2.17 -6.47% -6.91% 150K
|
Health Technology
|
| O: -24.46%
H: 12.95%
C: -29.5%
ad04 topline trial
Kraig Biocraft Laboratories Releases First Behind the Scenes Look into the Production of Recombinant Spider Silk
Published: 2022-07-20 (Crawled : 12:00) - biospace.com/
KBLB | $0.0854 -0.63% 330K
|
Mining, Quarrying, and Oil and ...
|
| O: 3.0%
H: 4.17%
C: 1.39%
Merck Provides Update on Phase 3 KEYNOTE-412 Trial in Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma
Published: 2022-07-20 (Crawled : 11:00) - biospace.com/
MRK | $125.23 -0.11% 0.0% 6M
|
Health Technology
|
| O: 0.0%
H: 0.07%
C: -2.93%
ynote-412 trial update cell carcinoma
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.